Table 1.
Patients’ characteristics
| Avalus | Magna | p value | |
|---|---|---|---|
| n = 87 | n = 381 | ||
| Age (years) | 73 [66, 79] | 70 [64, 76] | 0.022 |
| Male | 50 (58.1) | 231 (60.6) | 0.761 |
| Body surface area (m2) | 1.62 [1.47, 1.75] | 1.62 [1.49, 1.75] | 0.943 |
| Body mass index (kg/m2) | 22.7 [14.6, 35.4] | 22.8 [13.3, 32.6] | 0.148 |
| Valve pathology | |||
| Aortic stenosis | 41 (47.3) | 240 (63.0) | 0.001 |
| Aortic regurgitation | 36 (41.4) | 93 (24.4) | 0.005 |
| Mixed | 5 (5.7) | 24 (6.3) | 0.90 |
| Infective endocarditis | 3 (3.4) | 5 (1.3) | 0.84 |
| Prosthetic valve failure | 1 (1.1) | 15 (3.9) | 0.335 |
| Prosthetic valve endocarditis | 1 (1.1) | 4 (1.1) | 1 |
| Bicuspid aortic valve comorbidity | 25 (29.4) | 120 (33.2) | 0.583 |
| Coronary stenosis | 13 (14.9) | 76 (19.9) | 0.357 |
| Atrial fibrillation | 19 (22.1) | 60 (15.7) | 0.208 |
| Hypertension | 55 (63.2) | 285 (74.8) | 0.04 |
| Hyperlipidemia | 40 (46.0) | 190 (49.9) | 0.592 |
| Diabetes | 12 (13.8) | 66 (17.3) | 0.524 |
| HbA1c (%) | 5.8 [5.5, 6.1] | 5.5 [5.2, 5.9] | < 0.001 |
| Smoking | 36 (41.4) | 135 (35.4) | 0.36 |
| Carotid stenosis | 2 (2.3) | 10 (2.6) | 1 |
| Chronic kidney disease | 8 (9.2) | 22 (5.8) | 0.351 |
| Dialysis | 7 (8.0) | 8 (2.1) | 0.012 |
| Creatinine (mg/dl) | 0.91 [0.73, 1.14] | 0.85 [0.67, 1.01] | 0.019 |
| BNP (pg/ml) | 120 [54, 317] | 102 [44, 264] | 0.257 |
| New York Heart Association class | < 0.001 | ||
| I | 22 (25.3) | 22 (5.8) | |
| II | 55 (63.2) | 321 (84.3) | |
| III | 10 (11.5) | 33 (8.7) | |
| IV | 0 (0.0) | 5 (1.3) | |
| Risk score | |||
| Euro SCORE II | 1.8 [1.3, 2.9] | 1.6 [1.0, 3.2] | 0.613 |
| Japan score | 2.0 [1.4, 4.2] | 2.0 [1.3, 3.5] | 0.626 |
Data are presented as median (interquartile range) or number (%). HbA1c, haemoglobin A1c; BNP, brain natriuretic peptide; EuroSCORE, European System for Cardiac Operative Risk Evaluation; Japan SCORE, Japan System for Cardiac Operative Risk Evaluation